Chicago Ebola Preparedness Update. Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015

Similar documents
CDC Support for Exit Screening and Lessons Learned for Preparedness

(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb

IHR Emergency Committee on the 2014 / 15 Ebola outbreak in West Africa

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

Ebola Q & A. # Question Answer Modified


A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014

Supplementary Appendix

PROTECT YOURSELF PROTECT YOUR FAMILY PROTECT YOUR COMMUNITY from Ebola

Ebola by the Numbers: Not a Small-scale Killer Anymore

Maine Ebola Response Plan. Jane Coolidge PhD, RN DHHS, Maine CDC, PHEP

BRIDGING PEOPLE AND TECHNOLOGY Why Population Health Matters

RE: CIRCULAR 02/14 EBOLA - SOUTH AMERICAN COUNTRIES

Louise Gresham PhD MPH Fondation Mérieux. Ebola Panel IOM 19 November 2014

EBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health

Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

One Year Later, Where Does the U.S. Response to Ebola Stand?

Modeling the Ebola Outbreak in West Africa, DRAFT Not for attribution or distribution

Transmitted from animals to humans. Transmitted humans-to-human by body fluid contact

Responding to Ebola Virus Disease on Commercial Airlines

EBOLA RESPONSE ROADMAP

Preparations for Ebola Vaccine Deployment

Classroom Discussion Guide on Ethics and Public Health Emergencies

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone.

WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO

UNCLASSIFIED OPERATION UNITED ASSISTANCE SUMMARY Z October 14

Surveillance strategy during Phase 3 of the Ebola response

Ebola Facts. October 14, 2014

Prioritizing Life-Saving Point-of-Care (POC) Diagnostics in the Aftermath of an Outbreak. Global Health Mini University March 4, 2016

Update from the Business Continuity Working Group

Standard Project Report 2015

Clinical Case Management Guidelines of Ebola Virus Disease (EVD)

Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease

BUDGET REVISION OF SO FOR APPROVAL BY THE EXECUTIVE DIRECTOR

EBOLA SITUATION REPORT

How to safely ship human blood samples from suspected Ebola cases within a country by road, rail and sea

Daniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France

Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak

R&D for potential vaccines for the Ebola virus

Obtain a set of DNA sequences that includes the reference sample from Guinea and 15 Ebola DNA sequences from samples of patients in Sierra Leone.

Selection and use of Ebola in vitro diagnostic (IVD) assays

HOW TO BOOK RESERVATIONS ONLINE. Here are four easy steps to help you when booking your reservations online.

9. Chapter 9: Data Management Procedures

How to safely ship human blood samples from Lassa cases within a country by road, rail and sea

Survey of Private Sector Pharmacies and Medicine Stores in Montserrado County, Liberia

STATUS OF REVIEWS, AUTHORIZATIONS AND OVERSIGHT FOR CLINICAL TRIALS IN THE WHO AFRICAN REGION. Technical Document

MEANINGFUL USE CRITERIA PHYSICIANS

Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation

EBOLA RESPONSE IN LIBERIA COMMUNITY HEALTH VOLUNTEERS

b) Where is the Storage location(s)? (provide the location in the pharmacy, building and room numbers)

Guidance Note H1402 Packaging and Transport of waste from suspect

The Integration and Application of ISO 9001 and the NIAHO Requirements In Medical Equipment Management

City of Cleveland and Northeast Ohio Strategic National Stockpile (SNS) Receipt and Distribution Plan

SITUATION REPORT EBOLA RESPONSE RESPONSE ROADMAP SITUATION ROADMAP REPORT

MANAGING STAFF DURING CRISIS SITUATIONS

Using Complete Blood Cell Counts to Diagnose Disease

An Investigation into the Existing Capacity and Screening Procedures for Ebola at Jomo Kenyatta International Airport, Nairobi

DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88%

Ebola Virus Disease Outbreak West Africa, September 2014

Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays

TJEMS Drug Box Program Best Practices Reviewed: Updated: November 2015

The Journal of Infectious Diseases SUPPLEMENT ARTICLE

EBOLA crisis management In GUINEA

Ebola: A latent threat to Latin America. Are we ready?

VAE Questions and Case Studies

AIRPORT ADVERTISING BUFFALO, NY [BUF] AIRPORT MEDIA GUIDE

IGRAs for Serial Testing of Healthcare Workers

your hospitals, your health, our priority ATTENDANCE MANAGEMENT TW10/055 HR COMMITTEE DEPUTY DIRECTOR HR STAFF SIDE CHAIR HUMAN RESOURCES DIRECTORATE

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES

Super Sleuths. Grade Level: Basic. Duration: 45 minutes. Setting: classroom

Interfacility Transport of a Patient with

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Deciphering ethical assumptions about Stepped-Wedge Designs: The case of Ebola vaccine research

AVOID FOODBORNE ILLNESS

Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease

Your Prescription Drug [ or 20%] Plan with Refill By Mail

Ebola Disease Facts. For Community and Household Health. Prepared for the Liberia Annual Conference of the United Methodist Church

WHO STRATEGIC RESPONSE PLAN. West Africa Ebola Outbreak

Laboratory Research Ethics, Conduct and Safety

Off Label or On Target? The Ethics of Investigational and Compassionate Uses

2014 APHL Next Generation Sequencing (NGS) Survey

Emerging PACS Trends that Increase Imaging and Diagnostics Efficiency and Effectiveness

Human Resources and Pandemic Planning. Fitting The Pieces Together November 6-8, 2006

Asymptomatic infection and family contact patterns in households of Ebola Virus Disease survivors, Sierra Leone 2015

arxiv: v4 [q-bio.pe] 2 Sep 2014

MEDICAL BILLING ASSOCIATE

HCT/P Deviations & Reporting. 13 th ANNUAL FDA & The Changing Paradigm for HCT/P Regulation February 13-15, 2017

The pivotal role of airports

EFFECTS OF INFRASTRUCTURE ON EBOLA VIRAL DISEASE

Assessing Organizational Readiness

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety

Guidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order

VACCINE AND TB SKIN TEST INFORMATION

Transcription:

Chicago Ebola Preparedness Update Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015

Agenda Ebola Overview Crisis in West Africa Symptoms and transmission Chicago Preparedness Efforts Coordinated Effort O Hare Operations Chicago Ebola Resource Network Traveler Monitoring Healthcare Coalition

Graph 1: Total suspected, probable, and confirmed cases of Ebola virus disease in Guinea, Liberia, and Sierra Leone, March 25, 2014 March 1, 2015, by date of WHO Situation Report, n=23934

http://www.nytimes.com/2015/03/01/world/africa/near ly-beaten-in-sierra-leone-ebola-makes-a-comeback-bysea.html?_r=0

Graph 2: Total suspected, probable, and confirmed cases and deaths of Ebola virus disease in Guinea, March 25, 2014 March 1, 2015, by date of WHO Situation Report, n=3219 Graph 3: Total suspected, probable, and confirmed cases and deaths of Ebola virus disease in Liberia, March 25, 2014 March 1, 2015, by date of WHO Situation Report, n=9249 Graph 4: Total suspected, probable, and confirmed cases and deaths of Ebola virus disease in Sierra Leone, March 25, 2014 March 1, 2015, by date of WHO Situation Report, n=11466

Symptom Frequency in Symptom Current Outbreak % of cases (from symptom onset to detection) Fever 87% Fatigue 76% Vomiting 68% Diarrhea 66% Unexplained bleeding Blood in stool 18% 6%

The fluid must have an entry point, like a cut or scrape, or someone touching their nose, mouth, or eyes. Blood, feces, and vomit are the most infectious. Virus usually not found in saliva until patient is severely ill.

Chicago Response O Hare Operations 1. High risk travel hub 2. Traveler Screening 3. Transportation, housing, etc. Chicago Ebola Resource Network 1. Shared Responsibility for Care 2. Evaluation of PUIs Traveler Monitoring 1. Active Monitoring 2. Direct Active Monitoring 3. Inter/Intra State Coordination Healthcare System Preparedness 1. Network of Providers 2. All Area Hospitals and Clinics 3. EMS Providers

Airport Screening All individuals leaving Guinea, Liberia, and Sierra Leone are screened at exit from their country and entry into the US Exit Screening Temperature Questionnaire: Exposures and symptoms Entry Screening in US airports JFK, Dulles, Newark, Atlanta and Chicago O Hare Customs and Border Protection and CDC staff Temperature Questionnaire: Exposures and symptoms

Airport Operations CDPH staff on site daily to support CBP, CDC screening CDPH Role at ORD Issuance of controlled movement orders EMS coordination for transport of PUIs Coordination of housing, transportation, other needs for travel companions Compliance with City s Emergency Operations Plan OEMC DFSS American Red Cross

CDC Care Kit CARE kit introduction How to check and report your health for Ebola Digital thermometer How to use your thermometer to check your temperature Symptom card and log CDC CARE card Phone numbers for State and Local Health Departments

Ebola Contact Card

Risk Level Determination High risk: direct contact of infected body fluids of someone diagnosed with Ebola. This can include needle stick, or splashes to eyes, nose or mouth or handling body fluids in a laboratory, without wearing personal protective equipment (PPE) Some risk: close contact with a person showing symptoms of Ebola such as in a household, health care facility or community Low risk: having been in a country with widespread Ebola transmission within the previous 21 days and having no known exposure OR being in the same room/plane for a brief period of time with a person showing symptoms of Ebola

Arrival screening at O Hare Traveler has fever or other signs/symptoms consistent with Ebola Traveler is asymptomatic (i.e. no fever, no signs or symptoms of illness) but reports an exposure to Ebola during the 21 days before arrival Traveler is asymptomatic, and doesn t report exposure to Ebola during the 21 days before arrival Disposition Medical evaluation required If high risk exposure: Quarantine If some risk exposure: Conditional release If low risk exposure Active daily monitoring required? Possibly, if/when the patient is discharged YES YES YES

Resource Network Where will Symptomatic Travelers receive care? The Chicago Ebola Resource Network Rush University Medical Center, University of Chicago Medical Center, Northwestern Memorial Hospital, Lurie Children s Hospital of Chicago Network of hospitals identified with: Specialty care expertise (infectious disease, intensive care, dialysis), Resources to support usual care as well as care for an Ebola patient Laboratory capacity and systems Advanced infection control systems Waste management systems Willingness to care for Ebola patients CDC team assessed hospital readiness and training needs (10/19-10/23)

Appropriate Referrals Referral Source O Hare Hospitals Clinics ` Exposure Symptoms Provider Verification Guinea, Liberia, Sierra Leone in past 21 days Guinea, Liberia, Sierra Leone in past 21 days Guinea, Liberia, Sierra Leone in past 21 days Fever or any other symptoms consistent with Ebola Fever or any other symptoms consistent with Ebola Fever or any other symptoms consistent with Ebola CDC physician ID physician (in person or via phone) Physician in consultation with CDPH Community Guinea, Liberia, Sierra Leone in past 21 days Fever or any other symptoms consistent with Ebola Paramedics

Hospital Responsibilities Tiered approach: frontline, assessment treatment centers Evaluate patients presenting to ED Travel history Guinea, Liberia, Sierra Leone in past 21 days Identify symptoms consistent with Ebola Consult with ID physician to determine appropriateness to transport to network hospital Participate in inventory management reporting for PPE Make Ebola resources available to staff and train staff

Clinic Responsibilities Evaluate patients presenting to clinic Travel history Guinea, Liberia and Sierra Leone in past 21 days Identify symptoms consistent with Ebola Consult with CDPH physician to determine appropriateness to transport to network hospital Make Ebola resources available to staff and train staff Interim guidance and protocols provided by CDPH

PUIs 8 patients Age range 5-61yo 10/21/14-3/5/15 5 of 8 from O Hare Alternative dx: 3 malaria 1 typhoid fever 3 URI (influenza, coronavirus, non-specific) 1 dehydration

Asymptomatic Travelers

Arrival screening at O Hare Traveler has fever or other signs/symptoms consistent with Ebola Traveler is asymptomatic (i.e. no fever, no signs or symptoms of illness) but reports an exposure to Ebola during the 21 days before arrival Traveler is asymptomatic, and doesn t report exposure to Ebola during the 21 days before arrival Disposition Medical evaluation required If high risk exposure: Quarantine If some risk exposure: Conditional release If low risk exposure Active daily monitoring required? Possibly, if/when the patient is discharged YES YES YES

Monitoring Procedures Asymptomatic with low risk of exposure Allowed to continue traveling Local public health agencies required to monitor these individuals for 21 days following their arrival to final destination In-person visit at start and once/week thereafter Active monitoring with twice daily temp reporting and symptom checks Asymptomatic with some risk of exposure May not continue traveling on public airplanes Local public transit prohibited Local public health agencies required to monitor these individuals for 21 days following their arrival to final destination Direct active monitoring with twice daily temp reporting and symptom checks Daily in-person visit Staffed by PHNs, epidemiologist, med dir, admin assistant

Monitoring procedures Asymptomatic with high risk of exposure Home quarantine required May not continue traveling on public airplanes Local public transit prohibited Local public health agencies required to monitor these individuals for 21 days following their arrival to final destination

Monitored Individuals Chicago 10/17/14 3/17/15 62 individuals with one repeat traveler = 63 monitoring events First individual was a flight attendant, remainder were travelers to W. Africa 8 children (aged 1-17 yrs.) 1 lost to follow up x 1 w

Risk Level Monitored Individuals by Risk Level Chicago 10/17/14 3/17/15 # Comment Some 8 3 family members of a hospitalized person + 5 HCW who worked in W. Africa Low 54 Visiting or joining family, business trip, minister, aid workers, medical researcher Total 62

Healthcare System Preparedness

Healthcare System Preparedness Acquisition of appropriate PPE Guidance and treatment recommendations Frequent situational awareness calls Training Ebola Resource Network staff sent to Emory and University of Nebraska Infection control supplemental training for non- Ebola Resource Network hospitals Funding!

Funding Supplemental funding available via ASPR and CDC $4.8M Ebola Supplemental for AM/DAM (CDC) $145M Ebola Supplemental (CDC) $1M Ebola Supplemental for select cities (ASPR) New funding available for Ebola preparedness and response $106M ELC grant appropriation (CDC) $162M Ebola Preparedness and Response appropriation (ASPR) $32.5M Ebola competitive appropriation for regional Ebola treatment centers (ASPR)

Thank You. Questions.